Carbapenem resistance in Klebsiella pneumoniae due to the new delhi metallo-β-lactamase

Clinical Infectious Diseases

Volumn 52, Issue 4, 2011, Pages 481-484

  Sidjabat, Hanna ^a   Nimmo, Graeme R ^a,b   Walsh, Timothy R ^e   Binotto, Enzo ^b,c   Htin, Anthony ^c   Hayashi, Yoshiro ^a   Li, Jian ^d   Nation, Roger L ^d   George, Narelle ^b   Paterson, David L ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Pathology Queensland   (Australia)

^c CAIRNS BASE HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANATE POTASSIUM PLUS TICARCILLIN; COLISTIN; COTRIMOXAZOLE; DORIPENEM; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NALIDIXIC ACID; NEW DELHI METALLO BETA LACTAMASE PROTEIN; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; UNCLASSIFIED DRUG;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; CASE REPORT; DYSURIA; ESCHERICHIA COLI; FEMALE; FEVER; FOOT ULCER; GENE SEQUENCE; HUMAN; INDIA; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MINIMUM INHIBITORY CONCENTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AUSTRALIA; BACTERIAL TYPING TECHNIQUES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; FEMALE; HUMANS; INDIA; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; URINARY TRACT INFECTIONS;

EID: 79951829390     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq178     Document Type: Review

References (35)

1. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009;9:228-36.
2. Leavitt A, Carmeli Y, Chmelnitsky I, Goren MG, Ofek I, Navon-Venezia S. Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel. Antimicrob Agents Chemother 2010;54:3002-6.
3. Souli M, Galani I, Antoniadou A, et al. An outbreak of infection due to β-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 2010;50:364-73.
4. Bratu S, Landman D, Haag R, et al. Rapid spread of carbapenemresistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 2005;165:1430-5. (Pubitemid 40973427)
5. Peleg AY, Hooper DC. Hospital-acquired infections due to gramnegative bacteria. N Engl J Med 2010;362:1804-13.
6. Kitchel B, Rasheed JK, Patel JB, et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 2009;53:3365-70.
7. Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 1997;41:563-9. (Pubitemid 27098404)
8. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev 2005;18:306-25.
9. Souli M, Kontopidou FV, Papadomichelakis E, Galani I, Armaganidis A, Giamarellou H. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-β-lactamase in a Greek University Hospital. Clin Infect Dis 2008;46:847-54. (Pubitemid 351417185)
10. Franklin C, Liolios L, Peleg AY. Phenotypic detection of carbapenemsusceptible metallo-β-lactamase-producing gram-negative bacilli in the clinical laboratory. J Clin Microbiol 2006;44:3139-44. (Pubitemid 44413743)
11. Poirel L, Naas T, Nicolas D, et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid-and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 2000;44:891-7. (Pubitemid 30165266)
12. Sidjabat HE, Paterson DL, Adams-Haduch JM, et al. Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob Agents Chemother 2009;53:4733-9.
13. Sidjabat HE, Silveira FP, Potoski BA, et al. Interspecies spread of Klebsiella pneumoniae carbapenemase gene in a single patient. Clin Infect Dis 2009;49:1736-8.
14. Chen J, Griffiths MW. PCR differentiation of Escherichia coli from other gram-negative bacteria using primers derived from the nucleotide sequences flanking the gene encoding the universal stress protein. Lett Appl Microbiol 1998;27:369-71. (Pubitemid 28556439)
15. Antoniadou A, Kontopidou F, Poulakou G, et al. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother 2007;59:786-90. (Pubitemid 47073420)
16. Endimiani A, Patel G, Hujer KM, et al. In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin. Antimicrob Agents Chemother 2010;54:526-9.
17. Garrison MW, Mutters R, Dowzicky MJ. In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: tigecycline Evaluation and Surveillance Trial 2004 to 2007. Diagn Microbiol Infect Dis 2009;65:288-99.
18. Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 2009;30:666-71.
19. Lee J, Patel G, Huprikar S, Calfee DP, Jenkins SG. Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection. J Clin Microbiol 2009;47:1611-2.
20. Matthaiou DK, Michalopoulos A, Rafailidis PI, et al. Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med 2008;36:807-11.
21. Samonis G, Matthaiou DK, Kofteridis D, Maraki S, Falagas ME. In vitro susceptibility to various antibiotics of colistin-resistant gramnegative bacterial isolates in a general tertiary hospital in Crete, Greece. Clin Infect Dis 2010;50:1689-91.
22. Suh JY, Son JS, Chung DR, Peck KR, Ko KS, Song JH. Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea. Antimicrob Agents Chemother 2010;54:560-2.
23. Toth A, Damjanova I, Puskas E, et al. Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary. Eur J Clin Microbiol Infect Dis 2010;29:765-9.
24. Zarkotou O, Pournaras S, Voulgari E, et al. Risk factors and outcomes associated with acquisition of colistin-resistant KPC-producing Klebsiella pneumoniae: a matched case-control study. J Clin Microbiol 2010;48:2271-4.
25. Deshpande LM, Mendes RE, Castanheira M, Mathai D, Bell J, Jones RN. Dissemination of NDM-1-producing Enterobacteriaceae in India [abstract C2-701]. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy. Boston: American Society for Microbiology, 2010.
26. Kumarasamy K, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan and the UK: is this the end of conventional antibiotics for Enterobacteriaceae? Lancet Infect Dis 2010;10:597-602.
27. Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-β-lactamase gene, bla (NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009;53:5046-54.
28. Muir A, Weinbren MJ. New Delhi metallo-β-lactamase: a cautionary tale. J Hosp Infect 2010;75:239-40.
29. Centers for Disease Control and Prevention. Detection of Enterobacteriaceae isolates carrying metallo-β-lactamase-United States, 2010. MMWR Morb Mortal Wkly Rep 2010;59:750.
30. Poirel L, Revathi G, Bernabeu S, Nordmann P. Emergence of metallo-β-lactamase NDM-1 producing Klebsiella pneumoniaein Kenya [abstract C1-1334]. In: 50th Interscience Conference on Antimicrobial Agents and Chemotherapy. Boston: American Society for Microbiology, 2010.
31. Nordmann P. Current situation on spread of metallo-β-lactamases in Enterobacteriaceae [abstract C1-1331]. In: Interscience Conference on Antimicrobial Agents and Chemotherapy. Boston: American Society for Microbiology, 2010.
32. Pitout JD. The latest threat in the war on antimicrobial resistance. Lancet Infect Dis 2010;10:578-9.
33. Fernando GA, Collignon PJ, Bell JM. A risk for returned travellers: the "post-antibiotic era". Med J Aust 2010;193:59.
34. Poirel L, Lagrutta E, Taylor P, Pham J, Nordmann P. Emergence of metallo-ss-lactamase NDM-1-producing multidrug resistant Escherichia coli in Australia. Antimicrob Agents Chemother 2010;54:4914-6.
35. Peirano G, Ahmed-Bentley J, Woodford N, Pitout J. The characteristics of a metallo-β-lactamase producing Escherichia coli isolated in Canada from a patient with recent travel to India [abstract C1-675a]. In: 50th Interscience Conference on Antimicrobial Agents and Chemotherapy. Boston: American Society for Microbiology, 2010.